Skip to main content
Navigate back to homepage
Open search bar.
Open main navigation menu

Main navigation

  • Study
    UCL Portico statue
    Study at UCL

    Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.

    • Undergraduate courses
    • Graduate courses
    • Short courses
    • Study abroad
    • Centre for Languages & International Education
  • Research
    Tree-of-Life-MehmetDavrandi-UCL-EastmanDentalInstitute-042_2017-18-800x500-withborder (1)
    Research at UCL

    Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).

    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage
    UCL Print room
    Engage with UCL

    Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.

    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Public Policy
    • Schools and priority groups
    • Visit us
  • About
    UCL welcome quad
    About UCL

    Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.

    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
  • Active parent page: Brain Sciences
    • Study
    • Research
    • About the Faculty
    • Institutes and Divisions
    • Active parent page: News and Events
    • Contact

Cannabis-mimicking MS drug trial starts

Breadcrumb trail

  • Brain Sciences
  • News and Events

Faculty menu

  • Current page: Faculty news
  • Events

A trial has started of a treatment that mimics the properties of cannabis to help reduce spasticity associated with multiple sclerosis (MS). The trial is being led by Dr Rachel Farrell, a consultant at the National Hospital for Neurology and Neurosurgery (UCLH) and Honorary Senior Lecturer at the UCL Institute of Neurology.

One of the most common and disabling symptoms of MS, spasticity affects up to 80 per cent of patients, causing muscle stiffness, spasms and reduced mobility.

Many people with MS use cannabis medically to alleviate symptoms, but often suffer unwanted side effects like lethargy. Current treatments derived from cannabis are only moderately effective in reducing symptoms and also leave patients feeling fatigued and sedated.

The new drug, discovered at UCL, is called VSN16R and does not produce the sedative effect of current drugs. It was developed with the aim of finding a synthetic compound that interacts with the body’s own cannabinoid receptors without the disadvantages of other drugs.

Participants are only dosed for a four week period which is enough to show whether VSN16R impacts on spasticity. We hope to have the trial fully recruited within six to nine months and completed within a year. Dr Rachel Farrell, Consultant at the National Hospital for Neurology and Neurosurgery and Honorary Senior Lecturer at UCL Institute of Neurology

Our bodies produce what are known as cannabinoid receptors (proteins) in the brain which controls part of the brain involved in pain sensation, mood and memory. These receptors activate those parts of the brain when triggered by naturally-occurring chemicals known as endocannabinoids. Chemicals found in cannabis mimic the effect of endocannabinoids. VSN16R works on a neural pathway which controls excessive nervous excitability and so reduces the symptoms that result from damage caused by MS.

This project has been a collaboration between UCL drug design scientists and the neuroscience team at Queen Mary. This link between basic and clinical science in London has enabled the phase II trials of this new medicine – first beginning at UCLH and with Barts Health NHS Trust to join soon.

Further information:

  • UCLH website
  • NIHR Biomedical Research Centre

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources

UCL social media menu

  • Link to Soundcloud
  • Link to Flickr
  • Link to TikTok
  • Link to Youtube
  • Link to Instagram
  • Link to Facebook
  • Link to Twitter

University College London, Gower Street, London, WC1E 6BT

Tel: +44 (0) 20 7679 2000

© 2025 UCL

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in